Our Services
Medical Information
Helpful Resources
Published on: 10/5/2026
Women taking rosuvastatin (Crestor) report muscle aches, cramping, and weakness more often than men, partly because lower body weight, reduced kidney function, and interacting medications can raise drug levels in the blood. Rosuvastatin can also modestly increase fasting blood sugar and HbA1c, which may tip some women with prediabetes toward type 2 diabetes, though the cardiovascular benefit usually outweighs that risk. Dose, thyroid status, vitamin D levels, menopause, and other medications all influence how severe these effects become, so there are several important factors to consider before stopping or changing anything. See below to understand which muscle symptoms are harmless, which signal rare but serious rhabdomyolysis, and how blood sugar changes are typically monitored.
Because muscle aches and blood sugar shifts can stem from statins or from unrelated conditions like hypothyroidism, autoimmune myositis, or insulin resistance, sorting out the cause matters. A free, instant, online symptom check can help you organize your symptoms, see which explanations fit best, and know what to raise with your doctor next.
Last reviewed for medical accuracy: 10/04/2026
Rosuvastatin is a commonly prescribed statin used to lower “bad” LDL cholesterol and reduce the risk of heart disease. While it can offer significant benefits, women taking this medication should be aware of specific side effects, particularly muscle aches and changes in blood sugar. Below is an overview of what you need to know, drawn from credible sources such as the FDA prescribing information, Mayo Clinic, and professional cardiology guidelines.
Most women taking rosuvastatin will not have serious problems. The most frequent complaints include:
Two areas that deserve special attention are muscle-related symptoms and blood sugar changes.
Contact your healthcare provider if you notice:
Keep a Symptom Diary
Adjust Lifestyle Habits
Review All Medications
Discuss Dose Adjustments
Rosuvastatin side effects in females are usually mild, but certain symptoms require urgent evaluation:
If you experience any of the above, stop rosuvastatin and speak to a doctor right away.
Before you get a prescription refill or if you’re unsure about new symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a quick way to get personalized guidance and learn whether you should schedule a doctor’s appointment.
Always discuss any side effects or concerns with your healthcare provider. Bring your symptom diary and lab results to make the conversation easier. If you have life-threatening or serious symptoms, seek emergency care without delay.
By understanding rosuvastatin side effects in females and staying proactive about your health, you can enjoy the heart-protective benefits of this medication with confidence.
(References)
* Joy TR, Hegele RA. Narrative review: statin-related myopathy. Ann Intern Med. 2009 Jun 16;150(12):858-68. doi: 10.7326/0003-4819-150-12-200906160-00009. PMID: 19528564.
* Kones R. Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective. Drug Des Devel Ther. 2010 Dec 9;4:383-413. doi: 10.2147/DDDT.S10812. Epub 2010 Dec 9. PMID: 21267417; PMCID: PMC3023269.
* Sampson UK, Linton MF, Fazio S. Are statins diabetogenic? Curr Opin Cardiol. 2011 Jul;26(4):342-7. doi: 10.1097/HCO.0b013e3283470359. PMID: 21499090; PMCID: PMC3341610.
* Sheely D, Jialal I. Strategies to lower low-density lipoprotein cholesterol in metabolic syndrome: averting the diabetes risk. Metab Syndr Relat Disord. 2013 Jun;11(3):149-51. doi: 10.1089/met.2013.1503. Epub 2013 Mar 15. PMID: 23496028.
* Bragg DA, Walling A. Metabolic Syndrome: Hyperlipidemia. FP Essent. 2015 Aug;435:17-23. PMID: 26280341.
* Ochs-Balcom HM, Nguyen LM, Ma C, Isackson PJ, Luzum JA, Kitzmiller JP, Tarnopolsky M, Weisman M, Christopher-Stine L, Peltier W, Wortmann RL, Vladutiu GD. Clinical features related to statin-associated muscle symptoms. Muscle Nerve. 2019 May;59(5):537-543. doi: 10.1002/mus.26397. Epub 2019 Jan 11. PMID: 30549046; PMCID: PMC6465106.
* Vodička M, Slanař O, Pisár M, Šálek T. Rosuvastatin-induced rhabdomyolysis due to medication errors. Ceska Slov Farm. 2020 Spring;69(2):100-102. PMID: 32545989.
* Mashayekhi-Sardoo H, Atkin SL, Montecucco F, Sahebkar A. Potential Alteration of Statin-Related Pharmacological Features in Diabetes Mellitus. Biomed Res Int. 2021;2021:6698743. doi: 10.1155/2021/6698743. Epub 2021 Mar 26. PMID: 33834073; PMCID: PMC8018846.
* Krysiak R, Basiak M, Okopień B. Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia. Molecules. 2021 May 11;26(10). doi: 10.3390/molecules26102844. Epub 2021 May 11. PMID: 34064815; PMCID: PMC8151490.
* Kim BK, Hong SJ, Lee YJ, Hong SJ, Yun KH, Hong BK, Heo JH, Rha SW, Cho YH, Lee SJ, Ahn CM, Kim JS, Ko YG, Choi D, Jang Y, Hong MK, RACING investigators. Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial. Lancet. 2022 Jul 30;400(10349):380-390. doi: 10.1016/S0140-6736(22)00916-3. Epub 2022 Jul 18. PMID: 35863366.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.